模塑科技(000700.SZ):預計上半年淨利1.8億元-2億元 同比扭虧為盈
格隆匯7月14日丨模塑科技(000700.SZ)披露2021年半年度業績預吿,預計上半年歸屬於上市公司股東的淨利潤1.8億元–2億元,比上年同期上升255.57%-272.86%,扭虧為盈。基本每股收益約0.1963-0.2181元。
公司扭虧為盈,主要原因為:
由於上年同期受新型冠狀肺炎病毒疫情影響,公司收入大幅下滑,導致虧損。本報吿期,隨着收入恢復增長,海外虧損逐步減少,公司盈利能力逐步恢復;
報吿期內,非經常性損益對淨利潤的影響約為2830萬元,去年同期為-4926萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.